
Perfluorocarbon in vitreoretinal surgery and preoperative bevacizumab in diabetic tractional retinal detachment
Author(s) -
J. Fernando Arévalo,
Martín Serrano,
Juan D. Arias
Publication year - 2014
Publication title -
world journal of diabetes
Language(s) - English
Resource type - Journals
ISSN - 1948-9358
DOI - 10.4239/wjd.v5.i5.724
Subject(s) - medicine , diabetic retinopathy , ophthalmology , vitrectomy , bevacizumab , retinal detachment , vitreoretinal surgery , visual acuity , vitreous hemorrhage , phthisis bulbi , cataract surgery , prospective cohort study , retinal , surgery , diabetes mellitus , chemotherapy , endocrinology
To describe the en bloc perfluorodissection (EBPD) technique and to demonstrate the applicability of using preoperative intravitreal bevacizumab during small-gauge vitreoretinal surgery (23-gauge transconjunctival sutureless vitrectomy) in eyes with advanced proliferative diabetic retinopathy (PDR) with tractional retinal detachment (TRD).